WT1 and myelodysplastic syndrome: TCR-T cells specifically targeting Wilms’ tumor 1 (WT1; overexpressed in AML and MDS cells) demonstrated HLA-A*24:02-restricted cytotoxicity against WT1-expressing myeloid leukemias (147).